Wednesday, July 8, 2026

pharma · Pancreatic Adenocarcinoma · Cancer · ACTU

Actuate Therapeutics

News and analysis for Actuate Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

1751 River Run, Suite 400, Fort Worth, Texas 76107, US HQ
2015 Founded
16 Employees
Public company Type
ACTU · NYSE Ticker
Company details
Status
Public
HQ
1751 River Run, Suite 400, Fort Worth, Texas 76107, US
Founded
2015
Employees
16
Programs
12
Drugs
11
Patents
7
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Actuate Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Actuate Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Actuate Therapeutics yet.

Back to company overview →